»ó´Ü¿©¹é
±â»ç (Àüü 756°Ç)
[Sub Story] ¡°¾à ³Ê¹« ¸¹¾Æ Èûµé´Ù¡± ÀÌ»óµ· ±âÀÚ 2019-07-31 10:32
[Sub Story] ¡°Ç÷°ü¼º Ä¡¸Å ¸·À¸·Á¸é, °íÇ÷¾Ð °ü¸®°¡ ÃÖ¿ì¼±¡± ÀÌ»óµ· ±âÀÚ 2019-07-31 10:30
[Sub Story] ¡°´ç´¢º´ÀÇ µ¶¸³ÀûÀÎ À§ÇèÀÎÀÚ¡± ÀÌ»óµ· ±âÀÚ 2019-07-31 10:28
[Sub Story] Ç÷¾Ð¡¤ÁöÁú µ¿½Ã°ø·«ÇÏ¸é ½ÉÇ÷°ü»ç°Ç¡é ÀÌ»óµ· ±âÀÚ 2019-07-31 10:21
[Late Breaking Studies] °í·É 130mmhg ¹Ì¸¸¿¡ ³ú¹éÁúÇãÇ÷¼Õ»ó °³¼± ÀÌ»óµ· ±âÀÚ 2019-07-31 10:17
¶óÀÎ
[Interview] ¿©¼º °íÇ÷¾Ð, Æó°æ Àü°ú ÈÄ·Î ³ª´¶´Ù ÀÌ»óµ· ±âÀÚ 2019-07-31 10:04
[Sub Story] ºñ¸¸¼º °íÇ÷¾Ð¿¡ ¡°RAAS ¾ïÁ¦ Á߿䡱 ÀÌ»óµ· ±âÀÚ 2019-07-31 09:58
[Conference Report] ¡°¿Ö ¿ì¸° 6.5% ¹Ì¸¸Àΰ¡?¡± ÀÌ»óµ· ±âÀÚ 2019-07-30 17:49
[Conference Report] GLP-1 Á¦Á¦ ¡®´õ¡¯ °­·ÂÇÑ Ç×´ç´¢º´Á¦·Î ÁøÈ­ÇÒ±î? ÀÌ»óµ· ±âÀÚ 2019-07-30 17:43
[Drug Review] È£Èí±â Ä¡·á »õÈ°·Î ¸ð»öÇÑ´Ù ÀÌ»óµ· ±âÀÚ 2019-07-02 16:18
¶óÀÎ
[Interview] È£Èí±â ¸é¿ªÄ¡·á ¡°COPD ¾ÇÈ­À§Çè¿¡ ±àÁ¤ÇýÅá± ÀÌ»óµ· ±âÀÚ 2019-07-02 15:55
[Conference Report] Ç÷¾ÐÁ¶Àý·ü ¿Ã¸®±â À§ÇÑ Àü·«Àû ¼±ÅÃÀº? ÀÌ»óµ· ±âÀÚ 2019-07-02 14:34
[Conference Report] ¡°SGLT-2i·Î Ç÷´çÁ¶ÀýÇÒ±î ½ÉÇ÷°üº¸È£ÇÒ±î?¡± ÀÌ»óµ· ±âÀÚ 2019-07-02 14:30
[Sub Story] ³úÁ¹Áß È¯ÀÚ DAPT ±Þ¼º±â Á¶±âÄ¡·á·Î ´Ü±â°£ ±Ç°í ÀÌ»óµ· ±âÀÚ 2019-04-10 18:51
[Sub Story] ¡°¾à¹°¹ÝÀÀ ´Ù¸¥ µ¿¾Æ½Ã¾ÆÀΡ¦Ç×Ç÷¼ÒÆÇ¿ä¹ý Â÷º°È­Çؾߡ± ÀÌ»óµ· ±âÀÚ 2019-04-10 18:50
¶óÀÎ
[Deep in Guideline] ½ÉÇ÷°üÁúȯ 1Â÷¿¹¹æ Ç×Ç÷¼ÒÆÇ¿ä¹ýÀÇ ÇöÁּҴ¡¦ ÀÌ»óµ· ±âÀÚ 2019-04-10 18:47
[Cover Story] ¡®µ¿¾Æ½Ã¾ÆÀÎ Æз¯µ¶½º¡¯ ÀÓ»ó Ç×Ç÷ÀüÄ¡·á¿¡ ¿µÇâ ÀÌ»óµ· ±âÀÚ 2019-04-10 18:45
[Sub Story] Å»ýÀûÀ¸·Î Ç×Ç÷¼ÒÆÇÈ¿°ú ¿ìÀ§ Á¡Çϴ Ŭ·ÎÇǵµ±×·¼ ÀÌ»óµ· ±âÀÚ 2019-04-10 18:34
[Interview] ´ç´¢º´ ȯÀÚ ½ÉÇ÷°üÁúȯ 1Â÷¿¹¹æ¿¡ ½Ç·Î½ºÅ¸Á¹ ±Ù°Å½×±â ÇÑâ ÀÌ»óµ· ±âÀÚ 2019-04-10 18:31
[Sub Story] 3Á¦ Ç×Ç÷ÀüÄ¡·á ÃâÇ÷À§Çè ¾î¶»°Ô ±Øº¹Çϳª? ÀÌ»óµ· ±âÀÚ 2019-04-10 17:47
Back to Top